Animal Science

Animal Science

Based upon HS Pharmaceuticals’ silicate-based nanoparticle technology, licensees of the HSX technology are developing ointments to help aid wound healing and possibly tumor reduction for the companion-pet and equine markets.

These variations of the technology are anticipated to move into United States manufacturing and sales in Q3 2017, with European Union manufacturing and sales by Q1 2018.